Karos Pharmaceuticals' Series B Round

Karos Pharmaceuticals raised a round of funding on August 17, 2016. Investors include New Leaf Venture Partners.

Karos Pharmaceuticals is a privately held biopharmaceutical company developing therapeutic agents to modulate peripheral serotonin synthesis to treat orphan indications, including pulmonary arterial h…

Articles about Karos Pharmaceuticals' Series B Round: